157 related articles for article (PubMed ID: 34895425)
1. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
3. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
4. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of hypersensitive quantitative fecal immunochemical test and qualitative fecal occult blood test for colorectal cancer and advanced adenoma].
Zhou RC; Wang PZ; Ma MJ; Meng FY; Li YY; Zhang Y; Yang XY; Li YQ; Zuo XL
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3667-3672. PubMed ID: 36509537
[No Abstract] [Full Text] [Related]
6. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
7. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
8. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
[TBL] [Abstract][Full Text] [Related]
9. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
[TBL] [Abstract][Full Text] [Related]
10. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population.
Kong Y; Zhuo L; Dong D; Zhuo L; Lou P; Cai T; Chen S; Pan J; Gao Y; Lu H; Ma Y; Dong Z; Luo X; Zhao H
BMC Cancer; 2022 Sep; 22(1):961. PubMed ID: 36071414
[TBL] [Abstract][Full Text] [Related]
12. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
[TBL] [Abstract][Full Text] [Related]
13. [The optimal thresholds of the quantitative fecal immunochemical test for opportunistic screening of colorectal neoplasia].
Kang Q; Li N; Su H; Yang L; He YQ; Jia KM; Wang X; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):767-770. PubMed ID: 32192290
[No Abstract] [Full Text] [Related]
14. A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects.
Sung JJY; Wong MCS; Lam TYT; Tsoi KKF; Chan VCW; Cheung W; Ching JYL
J Gastroenterol Hepatol; 2018 Jan; 33(1):187-194. PubMed ID: 28561279
[TBL] [Abstract][Full Text] [Related]
15. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.
Tran CT; Nguyen MV; Tran MT; Tuong TT; Tran QH; Le LC; Pham HT; Bui NC; Vu HH; Nguyen TT; Ta PQ; Ha HT; Trinh DT; Bui HT; Trinh DQ; Van Nguyen K; Le SH; Van Vu K; Van Tran T; Tran HT; Shrubsole MJ; Ye F; Cai Q; Zheng W; Boffetta P; Shu XO; Luu HN
Jpn J Clin Oncol; 2022 Jul; 52(7):707-715. PubMed ID: 35383373
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Asia-Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta-analysis and systematic review.
Luu MN; Trinh NA; Tran TLT; Dang TP; Hiyama T; Quach DT
J Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38425009
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
[TBL] [Abstract][Full Text] [Related]
18. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
19. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
20. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.
Maeda Y; Gray E; Figueroa JD; Hall PS; Weller D; Dunlop MG; Din FVN
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34228096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
